Search for: "Oxford House, Inc." Results 101 - 120 of 151
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Nov 2008, 3:57 am
Political flurries and potential trade mark wars (Afro-IP) House arrest for DVD pirate (Afro-IP)   Spain Government to publish ‘Manual of Best Practices in the Prosecution of Infringing Activities’ (Class 46)   Ukraine Trade marks database to be accessible free of charge (Class 46)   United Arab Emirates Limitations on trademark protection (International Law Office)   United Kingdom Financing creative businesses (IP finance) UK patent… [read post]
20 Apr 2011, 5:31 am by Rob Robinson
White House) Online Tracking and Lawyer/Client Confidentiality - http://bit.ly/hsijpy (Anne Klinefelter) Rule 26(f) Checklist from Litigation Readiness: A Practical Approach to eDiscovery - http://tinyurl.com/3cpd7k2 (Oxford University Press) Social Networking, Users, and Reasonable Expectations of Privacy Under the Fourth Amendment - http://tinyurl.com/42vqlka (Junichi Semitsu) The Sedona Conference® Publishes "Database Principles" - http://tinyurl.com/3unfkym… [read post]
20 Nov 2007, 7:02 am
Box 901431 Kansas City, MO 64109 Phone: (816) 734-7068 Fax: (816) 734-7068 Goodwill Industries Easter Seals of Kansas, Inc 3636 North Oliver P.O. [read post]
6 Dec 2007, 7:45 am
Raleigh, NC 27673 Phone: (919) 733-9250; (V/TTY); (800) 821-6922 (V/TTY/Toll Free in NC only) Fax: (919) 733-9173 Pathways to the Future, Inc. 525 Mineral Springs Drive Sylva, NC 28779 Phone: (828) 631-1167(V/TTY) Fax: (828) 631-1169 E-mail: pathways@main.nc.us State ADA Coordinator Larry Jones NC Office on the ADA 217 West Jones Street Raleigh, NC 27603-1336 Phone: (919) 715-2302 (V/TTY) E-mail: Larry.Jones@ncmail.net Web: http://www.doa.state.nc.us/doa/ada/ada.htm ASSISTIVE… [read post]
23 Apr 2012, 3:04 am by INFORRM
Members to express their views responsibly without fear of judicial censorship; and invites Mr Speaker to consider what action the House might take to defend its rights against such attacks“. [read post]
8 May 2024, 2:26 pm by Kevin LaCroix
  The behavioral economics field gives us principles that suggest the loss of social security benefits will yield strong emotional and/or litigious responses, with the potential for carry-over into the private pension sphere.[7]  To  summarize why this is likely to occur: (1) individuals—using the status quo as their reference point—tend to view change as either a gain or a loss from the status quo; (2) “[s]ince losses loom larger [people feel them more… [read post]
6 Feb 2017, 4:57 am
New York: Oxford University Press, 2007. [read post]
4 Apr 2022, 8:00 am by INFORRM
This followed evidence provided by journalists and lawyers to the House of Lords Communications and Digital Committee on 31 March 2022 that the impact of SLAPP cases went deeper than court cases, with pre-court intimidation and the threat of costly legal proceedings meaning countless articles never get published. [read post]
5 Dec 2010, 4:00 am by Mandelman
At Time Inc. she was the assistant to the Chairman of the Board. [read post]
8 Jan 2024, 2:02 am by INFORRM
The Bill is currently in the Committee Stage of the House of Lords after its second reading on 19 December 2023. [read post]
25 Nov 2007, 7:20 am
Michigan 3401 East Saginaw, Suite 216 Lansing, MI 48912 Loan Fund Manager: Tim Strasz Phone: (517) 203-1200 Ext. 31 Fax: (517) 203-1203 E-mail: miatloanfund@aol.com Web: http://www.mi-atlf.org Michigan's Assistive Technology Project Michigan Disability Rights Coalition 780 West Lake Lansing Road, Suite 200 East Lansing, MI 48823 Phone: (517) 333-2477; (800) 760-4600 (Toll Free in MI only) E-mail: mdrc@match.org Web: http://www.copower.org Michigan Tech 2000 Michigan Assistive Technology… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
1 Feb 2023, 9:01 pm by renholding
As one House Committee Report stated, exempt offerings should be “a specific or an isolated sale of…securities to a particular person”[10] and were intended for limited transactions “where the public benefits are too remote. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]